Indivior PLC
INVVYOTCHealthcare
$21.85
+$0.00(+0.00%)
Market Cap$3.0B
P/E Ratio—
52W High$75.65
52W Low$14.76
Indivior PLC（INVVY）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · INVVY · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.90B | $0.79B | $0.65B | $0.79B |
| Cost of Revenue | $0.16B | $0.13B | $0.10B | $0.14B |
| Gross Profit | $0.74B | $0.66B | $0.55B | $0.65B |
| Gross Margin %(computed) | 82.35% | 83.94% | 85.01% | 82.17% |
| Operating Expenses | ||||
| R&D Expenses | $0.07B | $0.05B | $0.04B | $0.05B |
| G&A Expenses | $0.55B | $0.23B | $0.45B | $0.20B |
| Total Operating Expenses | $0.83B | $0.48B | $0.71B | $0.47B |
| Operating Income | ($0.09B) | $0.21B | ($0.16B) | $0.18B |
| Operating Margin %(computed) | -10.10% | 26.93% | -24.11% | 22.68% |
| Interest Income | $0.02B | $0.00B | $0.01B | $0.02B |
| Interest Expense | $0.03B | $0.03B | $0.03B | $0.02B |
| Income Before Tax | ($0.10B) | $0.19B | ($0.17B) | $0.18B |
| Income Tax Expense | ($0.04B) | ($0.01B) | ($0.03B) | $0.05B |
| Net Income | ($0.05B) | $0.20B | ($0.15B) | $0.13B |
| Net Margin %(computed) | -5.88% | 25.92% | -22.87% | 17.07% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-0.36 | $1.41 | $-0.96 | $0.90 |
| Wtd Avg Shares | 0.14B | 0.15B | 0.15B | 0.15B |
| EBITDA | ($0.05B) | $0.21B | ($0.12B) | $0.23B |
| EBITDA Margin %(computed) | -5.66% | 26.17% | -18.70% | 29.30% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Indivior PLC
关于Indivior PLC（INVVY）损益表
Indivior PLC（INVVY）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，INVVY实现营收$0.90B，毛利润$0.74B（毛利率82.35%），净利润($0.05B)（净利率-5.88%）。
常见问题
INVVY · 4 问Indivior PLC（INVVY）2022财年营收为$0.90B，同比up13.9%。
INVVY revenueINVVY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08